Skip to Main Content

Author Details

Timothy W Corson
Indiana University School of Medicine
2001
86
31
PMIDPaper TitleJournal TitlePublished Year
37940612Long-Acting Microparticle Formulation of Griseofulvin for Ocular Neovascularization Therapy.Small2024
37949286Retinoblastoma Outcomes in the Americas: A Prospective Analysis of 491 Children With Retinoblastoma From 23 American Countries.Am J Ophthalmol2024
36938984Antiangiogenic Pterocarpan and Flavonoid Constituents of <i>Erythrina lysistemon</i>.J Nat Prod2023
37142441Beyond VEGF: Targeting Inflammation and Other Pathways for Treatment of Retinal Disease.J Pharmacol Exp Ther2023
36720900PRMT5 is a therapeutic target in choroidal neovascularization.Sci Rep2023
36542352Synthesis and Structure Revision of Naturally Occurring Homoisoflavane (+)-Dracaeconolide B.J Nat Prod2023
36674619Identification of Novel Pathways Regulated by APE1/Ref-1 in Human Retinal Endothelial Cells.Int J Mol Sci2023
35090600Small-molecule inhibitors of ferrochelatase are antiangiogenic agents.Cell Chem Biol2022
36555236Decreased Expression of Soluble Epoxide Hydrolase Suppresses Murine Choroidal Neovascularization.Int J Mol Sci2022
36365089Mouse Pharmacokinetics and In Vitro Metabolism of SH-11037 and SH-11008, Synthetic Homoisoflavonoids for Retinal Neovascularization.Pharmaceutics2022
35990811An improved method for murine laser-induced choroidal neovascularization lesion quantification from optical coherence tomography images.MethodsX2022
34372837Building a virtual summer research experience in cancer for high school and early undergraduate students: lessons from the COVID-19 pandemic.BMC Med Educ2021
33675778A smartphone based method for mouse fundus imaging.Exp Eye Res2021
33620374Retinal Phenotyping of Ferrochelatase Mutant Mice Reveals Protoporphyrin Accumulation and Reduced Neovascular Response.Invest Ophthalmol Vis Sci2021
33645529Modulating a summer ophthalmology research experience for medical students during the COVID-19 pandemic.Int J Med Educ2021
34556761Patient preferences in retinal drug delivery.Sci Rep2021
34638620Inhibition of APE1/Ref-1 for Neovascular Eye Diseases: From Biology to Therapy.Int J Mol Sci2021
34322687APE1/Ref-1 as a Novel Target for Retinal Diseases.J Cell Signal2021
34027490Measurement of mitochondrial respiration in the murine retina using a Seahorse extracellular flux analyzer.STAR Protoc2021
32455225Total Synthesis of Naturally Occurring 5,7,8-Trioxygenated Homoisoflavonoids.ACS Omega2020
32082484Calcitriol and non-calcemic vitamin D analogue, 22-oxacalcitriol, attenuate developmental and pathological choroidal vasculature angiogenesis <i>ex vivo</i> and <i>in vivo</i>.Oncotarget2020
31927011Bufadienolides and anti-angiogenic homoisoflavonoids from Rhodocodon cryptopodus, Rhodocodon rotundus and Rhodocodon cyathiformis.Fitoterapia2020
32105305Global Retinoblastoma Presentation and Analysis by National Income Level.JAMA Oncol2020
33198208Cancer Research in the "Chemical Biology" Section of the Journal <i>Molecules</i>.Molecules2020
33322811NF-κB Signaling Is Regulated by Fucosylation in Metastatic Breast Cancer Cells.Biomedicines2020
32716567Ferrochelatase regulates retinal neovascularization.FASEB J2020
32760270Mitochondrial Heme Synthesis Enzymes as Therapeutic Targets in Vascular Diseases.Front Pharmacol2020
32755804Heme Synthesis Inhibition Blocks Angiogenesis via Mitochondrial Dysfunction.iScience2020
32751576Pharmacological Potential of Small Molecules for Treating Corneal Neovascularization.Molecules2020
32243127Phenotypic Screening of Chemical Libraries Enriched by Molecular Docking to Multiple Targets Selected from Glioblastoma Genomic Data.ACS Chem Biol2020
29314142Retinoblastoma, the visible CNS tumor: A review.J Neurosci Res2019
31381339Enantioselective Synthesis of Homoisoflavanones by Asymmetric Transfer Hydrogenation and Their Biological Evaluation for Antiangiogenic Activity.J Org Chem2019
31155061Small molecule target identification using photo-affinity chromatography.Methods Enzymol2019
30951308The Antiangiogenic Activity of Naturally Occurring and Synthetic Homoisoflavonoids from the Hyacinthaceae ( sensu APGII).J Nat Prod2019
30792659Soluble Epoxide Hydrolase Inhibition for Ocular Diseases: Vision for the Future.Front Pharmacol2019
30581134Small-Molecule Covalent Modification of Conserved Cysteine Leads to Allosteric Inhibition of the TEADâ¿¿Yap Protein-Protein Interaction.Cell Chem Biol2019
29193961Chemical Proteomics Reveals Soluble Epoxide Hydrolase as a Therapeutic Target for Ocular Neovascularization.ACS Chem Biol2018
30076264Ref-1/APE1 Inhibition with Novel Small Molecules Blocks Ocular Neovascularization.J Pharmacol Exp Ther2018
30385851Observations on spontaneous tumor formation in mice overexpressing mitotic kinesin Kif14.Sci Rep2018
30470597Small molecules inhibit ex vivo tumor growth in bone.Bioorg Med Chem2018
29490386Antiangiogenic Activity and Cytotoxicity of Triterpenoids and Homoisoflavonoids from Massonia pustulata and Massonia bifolia.Planta Med2018
28377496Ferrochelatase is a therapeutic target for ocular neovascularization.EMBO Mol Med2017
27318443Molecular analysis distinguishes metastatic disease from second cancers in patients with retinoblastoma.Cancer Genet2016
27481561Design, synthesis and biological evaluation of photoaffinity probes of antiangiogenic homoisoflavonoids.Bioorg Med Chem Lett2016
27270502Kif14 overexpression accelerates murine retinoblastoma development.Int J Cancer2016
27148944A novel small molecule ameliorates ocular neovascularisation and synergises with anti-VEGF therapy.Sci Rep2016
27529212Synthesis of Natural Homoisoflavonoids Having Either 5,7-Dihydroxy-6-methoxy or 7-Hydroxy-5,6-dimethoxy Groups.Molecules2016
25999678Optical coherence tomography enables imaging of tumor initiation in the TAg-RB mouse model of retinoblastoma.Mol Vis2015
27189421Retinoblastoma.Nat Rev Dis Primers2015
26035834Cancer genetics education in a low- to middle-income country: evaluation of an interactive workshop for clinicians in Kenya.PLoS One2015
  • 1 - 50 of 86

Recommended Authors

Noorda College of Osteopathic Medicine
Career Start Year 2014
Number of shared co-authors 0
Guangzhou Women and Children's Medical Center, Guangzhou Medical University
Career Start Year 2014
Number of shared co-authors 2
Research Center for Nano-Biomaterials, Sichuan University
Career Start Year 2013
Number of shared co-authors 2
Medical Center, University of Freiburg
Career Start Year 2010
Number of shared co-authors 0
Children's Hospital of Nanjing Medical University
Career Start Year 2009
Number of shared co-authors 0
The University of Sydney Save Sight Institute
Career Start Year 2005
Number of shared co-authors 0
The Chinese University of Hong Kong
Career Start Year 2005
Number of shared co-authors 1
Sun Yat-sen University
Career Start Year 2002
Number of shared co-authors 1
West China Second Hospital, Sichuan University
Career Start Year 2000
Number of shared co-authors 0
Keck School of Medicine of USC, University of Southern
Career Start Year 1999
Number of shared co-authors 0
Royal College of Surgeons in Ireland (RCSI)
Career Start Year 1999
Number of shared co-authors 0
Soonchunhyang University College of Medicine, Bucheon Hospital
Career Start Year 1999
Number of shared co-authors 0
Shiley Eye Institute, University of California
Career Start Year 1999
Number of shared co-authors 1
Chengdu Medical College
Career Start Year 1999
Number of shared co-authors 0
Uniformed Services University of the Health Sciences
Career Start Year 1997
Number of shared co-authors 0
The University of Melbourne, Peter MacCallum Cancer Centre
Career Start Year 1996
Number of shared co-authors 0
University of California San Diego
Career Start Year 1995
Number of shared co-authors 2
The Institute of Biomedical Sciences, East China Normal University
Career Start Year 1994
Number of shared co-authors 1
Washington University School of Medicine
Career Start Year 1994
Number of shared co-authors 0
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Career Start Year 1993
Number of shared co-authors 0
The University of Danang-University of Science and Technology
Career Start Year 1993
Number of shared co-authors 0
National Institutes of Health, National Center for Advancing Translational Sciences
Career Start Year 1992
Number of shared co-authors 0
University of Toronto
Career Start Year 1990
Number of shared co-authors 8
St. George's University Medical School
Career Start Year 1990
Number of shared co-authors 0
Harvard Medical School
Career Start Year 1989
Number of shared co-authors 0
College of Animal Science and Technology, Guangxi University
Career Start Year 1987
Number of shared co-authors 2
Mayo Clinic Jacksonville
Career Start Year 1982
Number of shared co-authors 0
Johns Hopkins University School of Medicine
Career Start Year 1980
Number of shared co-authors 2
the Scripps Research Institute
Career Start Year 1977
Number of shared co-authors 0
The Wilmer Eye Institute, Johns Hopkins University School of Medicine
Career Start Year 1976
Number of shared co-authors 0

Collaborators

The Eye Cancer Clinic, Princess Margaret Cancer Centre, Hospital for Sick Children
Co-authored papers 18
The Hospital for Sick Children
Co-authored papers 11
Ontario Institute for Cancer Research, University Avenue
Co-authored papers 5
Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children
Co-authored papers 5
Ontario Cancer Institute/Princess Margaret Hospital, University Health Network
Co-authored papers 3
University of Sao Paulo
Co-authored papers 2
Cancer Center Amsterdam
Co-authored papers 2
University of British Columbia.
Co-authored papers 2
University of Toronto
Co-authored papers 2
Institute of Human Genetics, University Hospital Essen, University Duisburg-Essen
Co-authored papers 2
University Health Network, University of Toronto
Co-authored papers 2
Co-authored papers 2
Toronto Western Hospital
Co-authored papers 2
Toronto Western Hospital
Co-authored papers 2
University of Toronto
Co-authored papers 1
INSERM U1245
Co-authored papers 1
Cancer Center Amsterdam
Co-authored papers 1
University of Alberta
Co-authored papers 1
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
Center for Cancer Research
Co-authored papers 1
Guangzhou Women and Children's Medical Center, Guangzhou Medical University
Co-authored papers 1
University of Pennsylvania
Co-authored papers 1
University of Toronto
Co-authored papers 1
Queen's University
Co-authored papers 1
VU University Medical Center
Co-authored papers 1
University of California los angeles
Co-authored papers 1
University of Alabama Callahan Eye Hospital and Clinics
Co-authored papers 1
Sloan Kettering Institute
Co-authored papers 1
University of Toronto
Co-authored papers 1
Ontario Institute for Cancer Research
Co-authored papers 1